TLC Announces Early Completion of Patient Enrollment in TLC590 Phase II Clinical Trial following Bunionectomy

NEXT STORY
Global Transplant Diagnostics Market Report 2020-2025 – Technological Advancements and Increasing Public-Private Funding for Target Research Activities Drive the Market
PREV STORY
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ERYTECH presenta gli sviluppi aziendali e la sua posizione finanziaria alla fine del primo trimestre 2020

author_avatar
NASDAQ Market News

EyePoint Pharmaceuticals Announces Completion of Enrollment of Phase 1 DAVIO Clinical Trial of EYP-1901 for the Potential Treatment of Wet AMD

author_avatar
NASDAQ Market News

Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update

 Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update Cash position at €75.9 ...

author_avatar
NASDAQ Market News